78,500 Shares in iShares Biotechnology ETF $IBB Purchased by Caption Management LLC

Caption Management LLC purchased a new stake in iShares Biotechnology ETF (NASDAQ:IBB) during the third quarter, according to its most recent disclosure with the SEC. The firm purchased 78,500 shares of the financial services provider’s stock, valued at approximately $11,333,000. Caption Management LLC owned approximately 0.19% of iShares Biotechnology ETF at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of the company. Volterra Technologies LP acquired a new stake in shares of iShares Biotechnology ETF in the third quarter worth approximately $1,948,000. Broyhill Asset Management LLC acquired a new position in iShares Biotechnology ETF in the 3rd quarter valued at $217,000. BTG Pactual Asset Management US LLC raised its stake in iShares Biotechnology ETF by 5.9% in the 3rd quarter. BTG Pactual Asset Management US LLC now owns 16,554 shares of the financial services provider’s stock valued at $2,390,000 after purchasing an additional 928 shares during the last quarter. Quantitative Investment Management LLC lifted its holdings in iShares Biotechnology ETF by 167.9% in the 3rd quarter. Quantitative Investment Management LLC now owns 4,362 shares of the financial services provider’s stock valued at $629,000 after purchasing an additional 2,734 shares in the last quarter. Finally, BNP Paribas Financial Markets lifted its holdings in iShares Biotechnology ETF by 313.2% in the 3rd quarter. BNP Paribas Financial Markets now owns 1,915,395 shares of the financial services provider’s stock valued at $276,526,000 after purchasing an additional 1,451,820 shares in the last quarter. 62.45% of the stock is currently owned by institutional investors and hedge funds.

iShares Biotechnology ETF Stock Down 0.4%

Shares of IBB opened at $165.51 on Friday. iShares Biotechnology ETF has a 52-week low of $107.43 and a 52-week high of $179.64. The firm’s fifty day moving average is $172.69 and its two-hundred day moving average is $162.38.

iShares Biotechnology ETF Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, December 19th. Investors of record on Tuesday, December 16th were given a dividend of $0.1831 per share. The ex-dividend date was Tuesday, December 16th. This is a boost from iShares Biotechnology ETF’s previous quarterly dividend of $0.08. This represents a $0.73 dividend on an annualized basis and a yield of 0.4%.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.